Results 1 to 10 of about 131,414 (209)
TREATMENT OF GINGIVAL HYPERPLASIA INDUCED BY NIFEDIPINE
Journal of Dentistry Indonesia, 2015 The use of Nifedipine as cardiovascular therapy is proven to be the cause of gingival hyperplasia. The objective of this present case is to report the gingival hyperplasia induced by nifedipine, and the best management suggested.
Mitayani Restuning Kusumarini +1 more
doaj +3 more sources
Cellular immunity indexes after therapeutic use of immunoactive and anti-inflammatory agents in patients with orthodontically induced gingival hyperplasia [PDF]
Pharmacia, 2021 Orthodontic treatment with fixed appliances that is mediated by the power forces of the apparatus might lead to changes in the blood circulation, predispose to a number of complications such as tooth movement and contributes to the morphological bone ...
Andrii Babenko +4 more
doaj +3 more sources
Amlodipine-induced gingival hyperplasia
National Journal of Physiology, Pharmacy and Pharmacology, 2021 Drug-induced gingival hyperplasia is the increased growth of gingival epithelium and submucosa which may cause bleeding and loss of teeth. Certain anticonvulsant, immunosuppressive, and antihypertensive drugs are the underlying cause in most cases. Among
Raghu N +3 more
doaj +1 more source
Amlodipine-induced gingival hyperplasia: A report of two cases
Journal of Clinical and Scientific Research, 2022 Drugs associated with gingival overgrowth fall into three broad categories – anticonvulsants, immune suppressants and calcium channel blockers. Amlodipine is a third-generation dihydropyridine. The prevalence of amlodipine-induced gingival hyperplasia is
G Sri Lakshmi +5 more
doaj +1 more source
Medically Induced Gingival Hyperplasia [PDF]
Mayo Clinic Proceedings, 1998 Gingival hyperplasia or gingival overgrowth is a common occurrence in patients taking phenytoin, cyclosporine, or calcium channel blockers. Speech, mastication, tooth eruption, and aesthetics may be altered. Controlling the inflammatory component through an appropriate oral hygiene program may benefit the patient by limiting the severity of the ...
S J, Meraw, P J, Sheridan
openaire +2 more sources
Idiopathic gingival fibromatosis: a case report and literature review
口腔疾病防治, 2020 Objective To explore the etiology, clinical manifestations, diagnosis, differential diagnosis and treatment of idiopathic gingival fibromatosis, and to provide references for clinical diagnosis and treatment.
ZHANG Limu, LIN Xiaoping
doaj +1 more source
Gingival hyperplasia in orthodontic patients: Case study
Saudi Dental Journal, 2019 Introduction: Gingival hyperplasia is a multi-factorial overgrowth of gingival tissues. Objectives: To evaluate orthodontic appliance association on gingival hyperplasia and examine a maintenance protocol to manage it.
Arwa Al-Oqlah +2 more
doaj +1 more source
Idiopathic Gingival Hyperplasia
International Journal of Biomedical Science, 2009 Gingival hyperplasia is a rare condition but it is important for cosmetic and mechanic reasons and because of its potential as an indicator of systemic disease. Gingival fibromatosis may exist as an isolated abnormality or as part of a syndrome. In this article a case that was diagnosed clinically and histologically as idiopathic gingival fibromatosis ...
Pirgon, Ozgur +2 more
openaire +3 more sources
Gingival Hyperplasia in a Patient With Hypertension [PDF]
The Journal of Clinical Hypertension, 2008 This case presentation is that of a 47-year old African American woman referred to the hypertension clinic by her cardiologist for difficult-to-treat hypertension. She had previously recorded blood pressure values of 110–235 ⁄70– 125 mm Hg on multiple occasions. She received nisoldipine 30 mg twice daily, losartan 100 mg daily, metoprolol succinate 200
A H, Tajani, Shawna D, Nesbitt
openaire +2 more sources
Amlodipine-Induced Gingival Hyperplasia: A Case Report [PDF]
Liaquat National Journal of Primary CareOne of the most prevalent chronic diseases in the world is hypertension. Numerous drug options are available in the medical treatment of the disease.
Elif Basaran, Gulali Aktas
doaj +1 more source